Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001750183-24-000010
Filing Date
2024-10-08
Accepted
2024-10-08 06:41:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13 G/A harrowhealth13ga.txt SC 13G/A 7432
  Complete submission text file 0001750183-24-000010.txt   9374
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Subject) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83793 | Film No.: 241359155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LEVEL 27, GOVERNOR PHILLIP TOWER, ONE FARRER PLACE SYDNEY C3 2000
Business Address LEVEL 27, GOVERNOR PHILLIP TOWER, ONE FARRER PLACE SYDNEY C3 2000 61 02 8006 5476
Ophir Asset Management Pty Ltd (Filed by) CIK: 0001844640 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G/A